{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T06:27:59Z","timestamp":1762064879303,"version":"build-2065373602"},"reference-count":50,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["PCN-2-063\/N\/1\/I"],"award-info":[{"award-number":["PCN-2-063\/N\/1\/I"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>We quantified galactosaminoglycans (GAAGs), oligomeric cartilage matrix protein (COMP), and human cartilage glycoprotein 39 (YKL-40) in blood obtained from juvenile idiopathic arthritis (JIA) before and during 2-year treatment with etanercept (ETA), as potential biomarkers of cartilage extracellular matrix (ECM) dysfunction and indicators of efficacy of biologic therapy. We also evaluated the relationship of the mentioned markers with the factors that regulate their metabolism, disintegrin and thrombospondin motif metalloproteinases 4 (ADAMTS4), ADAMTS5, and platelet-derived growth factor BB (PDGF-BB). Methods: We studied 38 children diagnosed with JIA and 45 healthy children. We quantified GAAGs by assessing the concentration of unsaturated disaccharide units formed by digestion of isolated glycosaminoglycans with chondroitinase ABC, while COMP, YKL-40, and PDGF-BB were quantified using immunoenzymatic methods. Results: Compared to the control group, GAAGs and COMP levels were significantly lower, while YKL-40 levels were higher in the blood of patients with aggressive JIA, qualified for ETA treatment. ETA therapy leading to clinical improvement simultaneously promoted normalization of COMP and YKL-40 levels, but not GAAGs. After 24 months of taking ETA, glycan levels were still significantly lower, relative to controls. GAAGs, COMP, and YKL-40 levels were significantly influenced by ADAMTS4, ADAMTS5, and PDGF-BB levels both before and during ETA treatment. Conclusions: The dynamics of changes in marker concentrations during treatment seem to indicate that measurement of COMP and YKL-40 levels can be used to assess the chondroprotective biological efficacy of therapy. In contrast, changes in GAAGs concentrations reflect systemic extracellular matrix transformations in the course of JIA.<\/jats:p>","DOI":"10.3390\/jcm11175069","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:01:31Z","timestamp":1661806891000},"page":"5069","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept\u2014Relationship with ADAMTS4, ADAMTS5, and PDGF-BB"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-3750","authenticated-orcid":false,"given":"Klaudia","family":"D\u0105bkowska","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-6217","authenticated-orcid":false,"given":"Magdalena","family":"Wojdas","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4762-4841","authenticated-orcid":false,"given":"Kornelia","family":"Ku\u017anik-Trocha","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8781-0011","authenticated-orcid":false,"given":"Grzegorz","family":"Wisowski","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gruenpeter","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The John Paul II Pediatric Center in Sosnowiec, ul. G. Zapolskiej 3, 41-218 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2307-5884","authenticated-orcid":false,"given":"Katarzyna","family":"Komosi\u0144ska-Vassev","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Olczyk","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-4133","authenticated-orcid":false,"given":"Katarzyna","family":"Winsz-Szczotka","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, ul. Jedno\u015bci 8, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4274\/balkanmedj.2017.0111","article-title":"Juvenile Idiopathic Arthritis","volume":"34","author":"Barut","year":"2017","journal-title":"Balkan Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wojdas, M., D\u0105bkowska, K., and Winsz-Szczotka, K. (2021). Alterations of Extracellular Matrix Components in the Course of Juvenile Idiopathic Arthritis. Metabolites, 11.","DOI":"10.3390\/metabo11030132"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular Matrix Structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bmb\/ldn025","article-title":"Articular Cartilage: Structure, Injuries and Review of Management","volume":"87","author":"Bhosale","year":"2008","journal-title":"Br. Med. Bull."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5604\/17322693.1196355","article-title":"Metabolism of Glycosaminoglycans in the Course of Juvenile Idiopathic Arthritis","volume":"70","author":"Mencner","year":"2016","journal-title":"Postepy Hig. Med. Dosw."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/03009742.2016.1192681","article-title":"Circulating Cartilage Oligomeric Matrix Protein in Juvenile Idiopathic Arthritis","volume":"46","author":"Lewander","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/147323000903700102","article-title":"YKL-40: A Potential Biomarker for Osteoarthritis","volume":"37","author":"Huang","year":"2009","journal-title":"J. Int. Med. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Winsz-Szczotka, K., Ku\u017anik-Trocha, K., Gruenpeter, A., Wojdas, M., D\u0105bkowska, K., and Olczyk, K. (2020). Association of Circulating COMP and YKL-40 as Markers of Metabolic Changes of Cartilage with Adipocytokines in Juvenile Idiopathic Arthritis. Metabolites, 10.","DOI":"10.3390\/metabo10020061"},{"key":"ref_9","first-page":"117","article-title":"Markery Immunologiczne w Diagnostyce i Prognozowaniu M\u0142odzienczego Idiopatycznego Zapalenia Staw\u00f3w i Reumatoidalnego Zapalenia Staw\u00f3w","volume":"10","author":"Smolewska","year":"2005","journal-title":"Alerg. Astma Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Winsz-Szczotka, K., Ku\u017anik-Trocha, K., Lach\u00f3r-Motyka, I., Lemski, W., and Olczyk, K. (2021). Concerted Actions by Piicp, Ctxii, and Tnf-\u03b1 in Patients with Juvenile Idiopathic Arthritis. Biomolecules, 11.","DOI":"10.3390\/biom11050648"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ku\u017anik-Trocha, K., Winsz-Szczotka, K., Lach\u00f3r-Motyka, I., D\u0105bkowska, K., Wojdas, M., Olczyk, K., and Komosi\u0144ska-Vassev, K. (2022). The Effects of TNF-\u03b1 Inhibition on the Metabolism of Cartilage: Relationship between KS, HA, HAPLN1 and ADAMTS4, ADAMTS5, TOS and TGF-\u03921 Plasma Concentrations in Patients with Juvenile Idiopathic Arthritis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11072013"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wojdas, M., Klaudia, D., Ku, K., and Wisowski, G. (2022). Plasma Glycosaminoglycans in Children with Juvenile Idiopathic Arthritis Being Treated with Etanercept as Potential Biomarkers of Joint Dysfunction. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081845"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the Extracellular Matrix in Development and Disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-4165(94)00123-F","article-title":"Qualitative and Quantitative Studies of Heparin and Chondroitin Sulfates in Normal Human Plasma","volume":"1243","author":"Volpi","year":"1995","journal-title":"BBA Gen. Subj."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0928-4680(97)00170-3","article-title":"Non-Insulin-Dependent Diabetes Mellitus-Associated Changes in Serum Glycosaminoglycans","volume":"4","author":"Olczyk","year":"1997","journal-title":"Pathophysiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2013.08.002","article-title":"Antioxidant Activity and Structural Modifications of Serum Chondroitin Sulfate in Graves\u2019 Disease","volume":"47","author":"Olczyk","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2014.026","article-title":"Analysis of Glycosaminoglycan-Derived, Precolumn, 2-Aminoacridone-Labeled Disaccharides with LC-Fluorescence and LC-MS Detection","volume":"9","author":"Volpi","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0003-2697(91)90372-Z","article-title":"Measurement of Uronic Acids without Interference from Neutral Sugars","volume":"197","author":"Carpita","year":"1991","journal-title":"Anal. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/abio.1997.2538","article-title":"A Microtiter Plate Assay for the Determination of Uronic Acids","volume":"257","author":"Barneveld","year":"1998","journal-title":"Anal. Biochem."},{"key":"ref_20","first-page":"7157169","article-title":"Laboratory Indicators of Aggrecan Turnover in Juvenile Idiopathic Arthritis","volume":"2016","author":"Olczyk","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/ar630","article-title":"Aggrecanases and Cartilage Matrix Degradation","volume":"5","author":"Nagase","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/ar1783","article-title":"ADAMTS Proteinases: A Multi-Domain, Multi-Functional Family with Roles in Extracellular Matrix Turnover and Arthritis","volume":"7","author":"Jones","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2015.02.018","article-title":"Plasma and Urinary Glycosaminoglycans in the Course of Juvenile Idiopathic Arthritis","volume":"458","author":"Wisowski","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.clinbiochem.2014.01.027","article-title":"Influence of Proteolytic-Antiproteolytic Enzymes and Prooxidative-Antioxidative Factors on Proteoglycan Alterations in Children with Juvenile Idiopathic Arthritis","volume":"47","author":"Gruenpeter","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1002\/art.34665","article-title":"Aggrecanase Cleavage in Juvenile Idiopathic Arthritis Patients Is Minimally Detected in the Aggrecan Interglobular Domain but Robust at the Aggrecan C-Terminus","volume":"64","author":"Struglics","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.35339\/ic.6.1.5-11","article-title":"Connective tissue metabolism in patients with juvenile idiopathic arthritis: 10-year follow-up study","volume":"6","author":"Panko","year":"2019","journal-title":"Inter Collegas"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117R","DOI":"10.1093\/glycob\/cwf066","article-title":"Dermatan Sulfate: New Functions from an Old Glycosaminoglycan","volume":"12","author":"Trownbridge","year":"2002","journal-title":"Glycobiology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13075-014-0429-9","article-title":"Current and Emerging Therapeutic Strategies for Preventing Inflammation and Aggrecanase-Mediated Cartilage Destruction in Arthritis","volume":"16","author":"Dancevic","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/art.22334","article-title":"Aggrecan Degradation in Human Articular Cartilage Explants Is Mediated by Both ADAMTS-4 and ADAMTS-5","volume":"56","author":"Song","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_31","first-page":"139","article-title":"The Regulation of the ADAMTS4 and ADAMTS5 Aggrecanases in Osteoarthritis: A Review","volume":"26","author":"Bondeson","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fbioe.2019.00469","article-title":"Growth Factor Engineering Strategies for Regenerative Medicine Applications","volume":"7","author":"Ren","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/wound.2011.0344","article-title":"Growth Factor\u2013Extracellular Matrix Interactions Regulate Wound Repair","volume":"1","author":"Wilgus","year":"2012","journal-title":"Adv. Wound Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13075-017-1238-8","article-title":"Excessive Activation of the TLR9\/TGF-\u03921\/PDGF-B Pathway in the Peripheral Blood of Patients with Systemic Lupus Erythematosus","volume":"19","author":"Yuan","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semarthrit.2015.06.006","article-title":"Peripheral Blood Cytokine and Chemokine Profiles in Juvenile Localized Scleroderma: T-Helper Cell-Associated Cytokine Profiles","volume":"45","author":"Torok","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.joca.2005.10.011","article-title":"A Review of the Effects of Insulin-like Growth Factor and Platelet Derived Growth Factor on in Vivo Cartilage Healing and Repair","volume":"14","author":"Schmidt","year":"2006","journal-title":"Osteoarthr. Cartil."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar2981","article-title":"Platelet-Derived Growth Factor and Transforming Growth Factor Beta Synergistically Potentiate Inflammatory Mediator Synthesis by Fibroblast-like Synoviocytes","volume":"12","author":"Rosengren","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00296-008-0805-3","article-title":"Synovial Fluid RANKL and Matrix Metalloproteinase Levels in Enthesitis Related Arthritis Subtype of Juvenile Idiopathic Arthritis","volume":"29","author":"Agarwal","year":"2009","journal-title":"Rheumatol. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/kei025","article-title":"Levels of Matrix Metalloproteinase (MMP)-1 in Paired Sera and Synovial Fluids of Juvenile Idiopathic Arthritis Patients: Relationship to Inflammatory Activity, MMP-3 and Tissue Inhibitor of Metalloproteinases-1 in a Longitudinal Study","volume":"44","author":"Peake","year":"2005","journal-title":"Rheumatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.55563\/clinexprheumatol\/ck090i","article-title":"Juvenile Idiopathic Arthritis Patients Have a Distinct Cartilage and Bone Biomarker Profile That Differs from Healthy and Knee-Injured Children","volume":"38","author":"Struglics","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_41","first-page":"33","article-title":"Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis","volume":"2009","author":"Tseng","year":"2009","journal-title":"Biomark. Insights"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncprheum0961","article-title":"The Role of ADAMTS-7 and ADAMTS-12 in the Pathogenesis of Arthritis","volume":"5","author":"Liu","year":"2009","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.080942","article-title":"Cartilage Oligomeric Matrix Protein in Patients with Juvenile Idiopathic Arthritis: Relation to Growth and Disease Activity","volume":"36","author":"Juul","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_44","first-page":"996","article-title":"Clinical Significance of Decreased Serum Concentration of Cartilage Oligomeric Matrix Protein in Systemic Juvenile Idiopathic Arthritis","volume":"33","author":"Urakami","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/joca.2000.0377","article-title":"Studies on YKL-40 in Knee Joints of Patients with Rheumatoid Arthritis and Osteoarthritis. Involvement of YKL-40 in the Joint Pathology","volume":"9","author":"Volck","year":"2001","journal-title":"Osteoarthr. Cartil."},{"key":"ref_46","first-page":"215140","article-title":"YKL-40 as a Novel Factor Associated with Inflammation and Catabolic Mechanisms in Osteoarthritic Joints","volume":"2014","author":"Koskinen","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/folmed-2017-0013","article-title":"YKL-40 and Cytokines\u2014A New Diagnostic Constellation in Rheumatoid Arthritis?","volume":"59","author":"Kazakova","year":"2017","journal-title":"Folia Med."},{"key":"ref_48","first-page":"92","article-title":"Serum YKL-40 Levels and Disease Characteristics in Patients with Rheumatoid Arthritis","volume":"10","author":"Ghorbanihaghjo","year":"2019","journal-title":"Casp. J. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"V\u00e4\u00e4n\u00e4nen, T., Vuolteenaho, K., Kautiainen, H., Nieminen, R., M\u00f6tt\u00f6nen, T., Hannonen, P., Korpela, M., Kauppi, M.J., Laiho, K., and Kaipiainen-Sepp\u00e4nen, O. (2017). Glycoprotein YKL-40: A Potential Biomarker of Disease Activity in Rheumatoid Arthritis during Intensive Treatment with CsDMARDs and Infliximab. Evidence from the Randomised Controlled NEO-RACo Trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183294"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/onc.2009.292","article-title":"YKL-40, a Secreted Glycoprotein, Promotes Tumor Angiogenesis","volume":"28","author":"Shao","year":"2009","journal-title":"Oncogene"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5069\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:19:39Z","timestamp":1760141979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":50,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jcm11175069"],"URL":"https:\/\/doi.org\/10.3390\/jcm11175069","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}